CalciMedica, Inc. Common Stock (CALC) is a publicly traded Healthcare sector company. As of May 21, 2026, CALC trades at $0.62 with a market cap of $9.79M and a P/E ratio of -0.33. CALC moved +3.63% today. Year to date, CALC is -89.27%; over the trailing twelve months it is -65.32%. Its 52-week range spans $0.46 to $7.20. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces CALC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CalciMedica Drops 2.1% to $5.73 on 51% Volume Decline: CalciMedica shares declined 2.1% on Tuesday, falling as low as $5.55 before closing at $5.73 on a 44,801-share volume, down 51% from the 92,307 average. Weiss Ratings reissued a “sell (d-)” grade, while analysts maintain a consensus $16.00 price target.
| Metric | Value |
|---|---|
| Price | $0.62 |
| Market Cap | $9.79M |
| P/E Ratio | -0.33 |
| EPS | $-1.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.20 |
| 52-Week Low | $0.46 |
| Volume | 430 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-29.56M |
| Gross Margin | 0.00% |
2 analysts cover CALC: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.